Switch to Europe/Worldwide website Switch to German website Switch to French website Switch to OriGene Technologies, Inc. (North America)
Home » Target » CYP2A13 antibody

CYP2A13 antibody

(reset)

Principal name

CYP2A13 antibody

Alternative names for CYP2A13 antibody

Cytochrome P450 2A13, CYPIIA13

SwissProt ID

Q16696 (Human)

Gene ID

1553 (CYP2A13)

Ncbi ID

NP_000757, 9606, NP_000757.2, AAI53001.1, NM_000766

Available reactivities

Hu (Human), Ms (Mouse), Por (Porcine), Rt (Rat), Can (Canine), Rb (Rabbit), Bov (Bovine), Eq (Equine), GP (Guinea Pig), Sh (Sheep)

Available hosts

Rabbit, Mouse

Available applications

Paraffin Sections (P), Immunocytochemistry/Immunofluorescence (ICC/IF), Western blot / Immunoblot (WB), ELISA (detection) (E(detection)), Enzyme Immunoassay (E), Immunoprecipitation (IP)

Background of CYP2A13 antibody

CYP2A13 is a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. Although its endogenous substrate has not been determined, it is known to metabolize 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a major nitrosamine specific to tobacco.This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. Although its endogenous substrate has not been determined, it is known to metabolize 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a major nitrosamine specific to tobacco. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q.

General readings

He,X.Y., (2004) Drug Metab. Dispos. 32 (12), 1516-1521

AP06775PU-N - CYP2A13
Western blot(WB) analyzes of CYP2A13 antibody (Cat.-No.: AP06775PU-N) in extracts from HeLa cells
H00001553-B01P - CYP2A13
Western Blot analysis of CYP2A13 expression in transfected 293T cell line (H00001553-T01) by CYP2A13 MaxPab polyclonal antibody.Lane 1: CYP2A13 transfected lysate(54.34 KDa).Lane 2: Non-transfected lysate.
ARP41803_T100 - CYP2A13
Human HepG2; WB Suggested Anti-CYP2A13 Antibody Titration: 5.0ug/ml. Positive Control: HepG2 cell lysate; CYP2A13 antibody - C-terminal region (ARP41803_T100) in Human HepG2 cells using Western Blot
H00001553-D01P - CYP2A13
Western Blot analysis of CYP2A13 expression in transfected 293T cell line (H00001553-T01) by CYP2A13 MaxPab polyclonal antibody.Lane 1: CYP2A13 transfected lysate(54.34 KDa).Lane 2: Non-transfected lysate.
AP17964PU-N - CYP2A13
Western blot analysis of CYP2A13 Antibody (C-term) (AP17964PU-N) in MDA-MB231 cell line lysates (35ug/lane). CYP2A13 (arrow) was detected using the purified Pab.
C12260-1 - CYP2A13
Western blot analysis of extracts from HeLa/293/A549 cells, using Cytochrome P450 2A13 Antibody. The lane on the right is treated with the synthesized peptide.
CPA1311-100ul - CYP2A13
Immunohistochemical analysis of Cytochrome P450 2A13 staining in human lung cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
CPA1311-100ul - CYP2A13
Immunofluorescent analysis of Cytochrome P450 2A13 staining in HepG2 cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 C in a humidified chamber. Cells were washed with PBST and incubated with a DyLight 594-conjugated secondary antibody (red) in PBS at room temperature in the dark. DAPI was used to stain the cell nuclei (blue).
CPA1311-100ul - CYP2A13
Western blot analysis of Cytochrome P450 2A13 expression in HepG2 (A) whole cell lysates.
TA313721 - CYP2A13
Western blot analysis of extracts from HeLa cells, 293 cells and A549 cells, using Cytochrome P450 2A13 antibody.The lane on the right is treated with the synthesized peptide.
TA346221 - CYP2A13
WB Suggested Anti-CYP2A13 Antibody Titration: 5.0 ug/ml; Positive Control: HepG2 cell lysate

3 Item(s)

per page

Primary Antibodies

Catalog No. Host Iso. Clone Pres. React. Applications  

CYP2A13 antibody
  Rabbit polyclonal Cytochrome P450 2A13 antibody  
Western blot analysis of extracts from HeLa cells, 293 cells and A549 cells, using Cytochrome P450 2A13 antibody.The lane on the right is treated with the synthesized peptide. Rabbit IgG Purified Hu E, WB
0.1 ml / $335.00
  OriGene Technologies, Inc.

CYP2A13 antibody
Western blot(WB) analyzes of CYP2A13 antibody (Cat.-No.: AP06775PU-N) in extracts from HeLa cells Rabbit Aff - Purified Hu ICC/IF, P, WB
0.1 mg / $370.00
  OriGene Technologies GmbH

CYP2A13 (C-term) antibody
Western blot analysis of CYP2A13 Antibody (C-term) (AP17964PU-N) in MDA-MB231 cell line lysates (35ug/lane). CYP2A13 (arrow) was detected using the purified Pab. Rabbit Hu WB
0.4 ml / $415.00
  OriGene Technologies GmbH

3 Item(s)

per page

Available Filters

Product Type
  1. Primary Antibody (3)
Clonality
  1. Polyclonal (3)
Target
  1. CYP2A13 (3)
Property
  1. C-term (1)
Reactivity
  1. Human (Hu) (3)
Applications
  1. Western blot / Immunoblot (WB) (3)
  2. Enzyme Immunoassay (E) (1)
  3. Immunocytochemistry/​Immunofluorescence (ICC/IF) (1)
  4. Paraffin Sections (P) (1)
Presentation
  1. Aff - Purified (1)
  2. Purified (1)
Host
  1. Rabbit (3)
Images
  1. 1 image (3)
Images: Applications
  1. Western blot / Immunoblot (WB) (3)
Manufacturer
  1. OriGene Technologies (3)
Service
 
© Copyright 1998 - 2018 OriGene Technologies, Inc.
  • LinkedIn